Comparable monthly disclosures
Institutional Activity
Where disclosed mutual fund positions are increasing, reducing, opening or closing.
Portfolio increases
Jan 2024 · Ranked across companies with at least 10 comparable portfolios
| Company | Portfolio increases | Comparable change | Portfolios increasing | Portfolios reducing | Comparable portfolios |
|---|---|---|---|---|---|
| Adani Energy Solutions Limited ADANIENSOL | 12 66.7% of comparable | -77,316 | 12 | 4 | 18 |
| Bajaj Holdings & Investment Limited BAJAJHLDNG | 12 52.2% of comparable | +49,049 | 12 | 5 | 23 |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO | 12 46.2% of comparable | -91,279 | 12 | 6 | 26 |
| Supreme Industries Limited SUPREMEIND | 12 35.3% of comparable | +0.03 Cr | 12 | 6 | 34 |
| MRF Limited MRF | 12 42.9% of comparable | -16,488 | 12 | 6 | 28 |
| ACC Limited ACC | 12 17.4% of comparable | -0.05 Cr | 12 | 8 | 69 |
| Solar Industries India Limited SOLARINDS | 12 36.4% of comparable | -0.03 Cr | 12 | 8 | 33 |
| Dr. Lal Path Labs Ltd. LALPATHLAB | 12 40.0% of comparable | +52,031 | 12 | 8 | 30 |
| K.P.R. Mill Limited KPRMILL | 12 28.6% of comparable | +0.10 Cr | 12 | 9 | 42 |
| Biocon Limited BIOCON | 12 25.0% of comparable | -0.41 Cr | 12 | 10 | 48 |
| Sumitomo Chemical India Limited SUMICHEM | 11 45.8% of comparable | +0.06 Cr | 11 | 2 | 24 |
| Sonata Software Limited SONATSOFTW | 11 44.0% of comparable | +0.04 Cr | 11 | 2 | 25 |
| Sundaram Finance Limited SUNDARMFIN | 11 45.8% of comparable | +27,856 | 11 | 2 | 24 |
| Prestige Estates Projects Limited PRESTIGE | 11 40.7% of comparable | -0.15 Cr | 11 | 2 | 27 |
| Granules India Limited GRANULES | 11 52.4% of comparable | +80,629 | 11 | 3 | 21 |
| Adani Total Gas Limited ATGL | 11 73.3% of comparable | -30,163 | 11 | 3 | 15 |
| CG Power and Industrial Solutions Limited CGPOWER | 11 28.2% of comparable | +0.62 Cr | 11 | 4 | 39 |
| 3M India Limited 3MINDIA | 11 25.6% of comparable | -6,766 | 11 | 4 | 43 |
| Crisil Limited CRISIL | 11 47.8% of comparable | -25,158 | 11 | 5 | 23 |
| Mankind Pharma Limited MANKIND | 11 24.4% of comparable | -68,199 | 11 | 5 | 45 |
| Gland Pharma Limited GLAND | 11 21.6% of comparable | +0.05 Cr | 11 | 6 | 51 |
| Tata Elxsi Limited TATAELXSI | 11 42.3% of comparable | -20,584 | 11 | 6 | 26 |
| Laurus Labs Limited LAURUSLABS | 11 30.6% of comparable | +0.07 Cr | 11 | 6 | 36 |
| Navin Fluorine International Limited NAVINFLUOR | 11 20.4% of comparable | -0.08 Cr | 11 | 7 | 54 |
| Indiamart Intermesh Limited INDIAMART | 11 42.3% of comparable | -88,755 | 11 | 7 | 26 |
How to read this activity
Activity compares disclosed positions for economic portfolios observed in both relevant monthly disclosures and adjusts for externally evidenced corporate actions where available.
At least 10 comparable portfolios are required. Companies under corporate-action review are excluded. Counts are unweighted by portfolio size, and share changes are quantities rather than market values; zero counts can appear at the end of a ranking. Breadth change is the change in AMCs holding, and can also reflect reporting coverage.
Full methodology →